Eurocom wins dermal filler account

pharmafile | June 10, 2011 | News story | Medical Communications Eurocom, medical communications 

Eurocom Healthcare Communications has been appointed to manage marketing communications for Ellansé, a novel family of dermal fillers.

The London-based communications agency’s managing director Tony Chant said: “We’re really excited by this recent account win – we’ve accrued a great deal of market knowledge creating marketing communication campaigns for several of the leading dermal filler brands.

“It’s clear that Ellansé is an exceptional dermal filler and truly unique with regards to the technology involved – as recognised by the recent Frost and Sullivan award.”

AQTIS Medical, the Dutch company behind Ellansé, recently took the 2011 Frost & Sullivan European Technology Innovation of the Year Award in recognition of their pioneering dermal fillers.

Advertisement

Dominic Tyer

Related Content

Rare diseases – spinal muscular atrophy

Spinal muscular atrophy (SMA) is a rare disease characterised by voluntary muscle weakness that can …

Digital mental health technologies – a valuable tool in supporting people with depression and anxiety

The potential benefits of digital mental health technology for managing depression, anxiety and stress, together …

Men’s health – a new report from the Department of Health and Social Care

The UK Department of Health and Social Care has published a new report entitled Men’s …

The Gateway to Local Adoption Series

Latest content